UnitedHealthcare Unveils Broad 2026 Policy Updates Affecting Medicare, Medicaid, Commercial Plans
UnitedHealthcare has announced a range of policy updates and program changes effective from late 2025 to early 2026 that impact Medicare, Medicaid, Exchanges, and commercial health plans across multiple states. These updates include revisions to medical and reimbursement policies, adjustments in specialty drug programs, and expanded coverage benefits in states such as Arizona and Massachusetts. Notable enhancements involve new Medicaid coverage for cochlear implants and speech therapy in Arizona and updated encounter data requirements for Massachusetts Medicaid to prevent claim denials and delays. Several Medicaid programs are introducing operational improvements, including reimbursement for gross receipt taxes in New Mexico, new non-emergency medical transportation vendors in Texas, and an updated primary care provider attribution process in Washington. North Carolina Medicaid adopted FDA-approved self-collected HPV tests for cervical cancer screening, reflecting evolving clinical guideline incorporation. UnitedHealthcare’s Medicare Advantage plans will see major changes, including new referral requirements for specialist visits beginning in 2026 and modifications in post-acute care management in select states. The Medicare Special Needs Plans (SNP) will require verification of chronic conditions for benefit access, and the discontinuation of Pfizer's Vyndaqel drug will affect impacted members by the end of 2025. Additional operational reforms involve streamlining prior authorization requirements by removing them for certain radiology and cardiology procedures, while increasing documentation standards for cardiac ablation and joint replacement surgeries. Commercial health plans will adopt updated pharmacy drug lists and benefit structures. Technological solutions such as Optum Recoveries’ Electronic Payment Portal and the new TrackIt platform aim to improve claims processing efficiency, allowing providers to manage claim overpayments and submit documentation for pended claims digitally. Providers are also encouraged to utilize shared decision-making tools for colorectal cancer screening and to conduct social determinants of health screenings to identify patient needs in housing, food, and transportation. These comprehensive updates reflect UnitedHealthcare’s ongoing efforts to align clinical policies with regulatory requirements, improve provider and member experience, and adapt to evolving healthcare delivery models across their network.